Senior Specialist, QC Analytical, Cell Therapy A2 Shift jobs in United States
cer-icon
Apply on Employer Site
company-logo

Bristol Myers Squibb · 2 days ago

Senior Specialist, QC Analytical, Cell Therapy A2 Shift

Bristol Myers Squibb is a biopharmaceutical company focused on transforming patients' lives through science. The Senior Specialist in QC Analytical will be responsible for supporting QC testing for in-process, final product, and stability samples, including data review and verification, method troubleshooting, and continuous improvement efforts.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
H1B Sponsor Likelynote

Responsibilities

Perform method transfer/validation and routine testing of in-process, final product, and stability samples
Anticipate and perform routine troubleshooting and problem solving with minimal guidance
Perform data verification, data review and review of GMP documentation for general and complex methods
Perform document revision, project, CAPA and deviation/ investigation related tasks and/ or continuous improvement efforts
Train and mentor others on QC test methods, processes and procedures
Perform other tasks as assigned

Qualification

CGMP requirementsAnalytical testingCellMolecular biologyLIMSTechnical writingProblem-solvingEffective communicationTeamwork

Required

Ability to accurately and completely understand, follow, interpret and apply Global Regulatory and cGMP requirements
Demonstrated technical writing skills
High problem-solving ability/mentality, technically adept and logical
Ability to communicate effectively with peers, department management and cross-functional peers about task status, roadblocks and needs
Ability to work in a fast-paced team environment, meet deadlines, and prioritize work
Bachelor's degree or equivalent required, preferably in science. Netherlands Bachelor's degree / HLO in (bioanalytical) science required
4+ years of relevant analytical testing or QC experience or equivalent combination of education and experience, preferably in a regulated environment
Demonstrated experience in cell and molecular biology techniques (e.g., cell-based assays, flow cytometry, qPCR, ELISA, and aseptic technique)

Preferred

Advanced knowledge of LIMS, ELN and laboratory data analysis systems

Benefits

Health Coverage Medical, pharmacy, dental, and vision care.
Wellbeing Support Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.

Company

Bristol Myers Squibb

company-logo
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.

H1B Sponsorship

Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)

Funding

Current Stage
Public Company
Total Funding
$29.32B
Key Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B

Leadership Team

leader-logo
Charles Bancroft
CFO
linkedin
leader-logo
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
linkedin
Company data provided by crunchbase